VRTX Vertex Pharmaceuticals Incorporated
349.53 -4.75 (-1.34%)
Market ClosedDelayed Prices By NASDAQ, in USD
VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated price
-0.19% Past Week
Market Cap
90.21B
Dayβs Range
52W Range
Volume (3M)
1.02M
Price-Earnings Ratio
27.02
Revenue
9.36B
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. The firm was founded in 1989, and its primary focus is on the researching and marketing of biotechnology solutions for the treatment of cystic fibrosis. The company has a number of approved therapies available that are aimed at the treatment of the underlying cause of cystic fibrosis.
The company also operates advanced independent research and development programs in other areas, and has a number of investigational small molecule medicines in their pipeline, aimed at treating kidney diseases, pain, and genetic diseases such as sickle cell disease, Duchenne muscular dystrophy and Type 1 diabetes.
Vertex Pharmaceuticals works in collaboration with Cystic Fibrosis Foundation Therapeutics Incorporated, CRISPR Therapeutics AG, and other organisations, and markets its products mainly to specialty healthcare providers in North America, as well as global government-owned providers. The firm has regularly been ranked as one of the industry's best places to work, including making Science Magazine's Top Employers list for 11 consecutive years, and being named a top place to work for LGBTQ equality by the Human Rights Campaign. The firm trades on the NASDAQ under the ticker VRTX.
Learn more about the share price performance of VRTX on eToro.
Show MoreReshma Kewalramani, MD
CEO
4.8K
Employees
1989
Founded
Boston, Massachusetts, US
HQ
Upcoming Events
26
OCT
REPORTS
Vertex Pharmaceuticals Incorporated Q3 2023 earnings report is expected to be released after market open
Consensus
Strong Buy
Price Target
385.25
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
65
Very High
Industry
Avg. 47
55
Environment
63
Social
72
Governance
People Also Bought
- REGN Regeneron Pharmaceuticals 0.18%
- NVS Novartis ADR -0.93%
- AZN AstraZeneca PLC ADR 1.21%
- ISRG Intuitive Surgical Inc 1.35%
- IDXX IDEXX Laboratories Inc -0.67%